123 related articles for article (PubMed ID: 38554345)
1. Clinicopathological and prognostic significance of VEGF, PDGF-B, and HER2/neu expression in gallbladder cancer.
Shukla P; Mishra K; Shukla R; Vishwakarma R; Kumari N; Krishnani N; Behari A; Kapoor VK
J Cancer Res Ther; 2024 Jan; 20(1):349-357. PubMed ID: 38554345
[TBL] [Abstract][Full Text] [Related]
2. Expression of VEGF-A, HER2/neu, and
Singh P; Jain SL; Sakhuja P; Agarwal A
Indian J Pathol Microbiol; 2021; 64(4):687-692. PubMed ID: 34673587
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of estrogen receptor 1 and vascular endothelial growth factor A expression in primary gallbladder carcinoma.
Zhang LQ; Xu XS; Wan Y; Song SD; Wang RT; Chen W; Wang ZX; Chang HL; Wei JC; Dong YF; Liu C
World J Gastroenterol; 2015 Jan; 21(4):1243-50. PubMed ID: 25632198
[TBL] [Abstract][Full Text] [Related]
4. Expression of ER, PR, and HER-2 Neu and correlation with tumor markers in gall bladder carcinoma.
Mani R; Gupta A; Gupta S; Goyal B; Mishra R; Tandon A; Sharma O; Rohilla KK; Kishore S; Dhar P
J Cancer Res Ther; 2023; 19(5):1279-1287. PubMed ID: 37787296
[TBL] [Abstract][Full Text] [Related]
5. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological features and CCT2 and PDIA2 expression in gallbladder squamous/adenosquamous carcinoma and gallbladder adenocarcinoma.
Zou Q; Yang ZL; Yuan Y; Li JH; Liang LF; Zeng GX; Chen SL
World J Surg Oncol; 2013 Jun; 11():143. PubMed ID: 23782473
[TBL] [Abstract][Full Text] [Related]
7. Expression of Human Epidermal Growth Factor Receptor (Her 2/neu) and Proliferative Marker Ki-67: Association with Clinicopathological Parameters in Gallbladder Carcinoma.
Pujani M; Makker I; Makker A; Jetley S; Goel MM; Jetley S
Asian Pac J Cancer Prev; 2016; 17(8):3903-9. PubMed ID: 27644637
[TBL] [Abstract][Full Text] [Related]
8. Expression of vascular endothelial growth factor and HER2/neu in stage II colon cancer and correlation with survival.
Ochs AM; Wong L; Kakani V; Neerukonda S; Gorske J; Rao A; Riggs M; Ward H; Keville L
Clin Colorectal Cancer; 2004 Nov; 4(4):262-7. PubMed ID: 15555209
[TBL] [Abstract][Full Text] [Related]
9. HER-2/neu over expression in gall bladder adenocarcinoma: A quest for potential therapeutic target.
Jain P; Goyal S; Chauhan G; Majumdar K; Ali S; Sakhuja P; Agarwal AK
Indian J Pathol Microbiol; 2020; 63(2):214-220. PubMed ID: 32317518
[TBL] [Abstract][Full Text] [Related]
10. [Expression of Her2/neu in locally advanced bladder cancer: implication for a molecular targeted therapy].
Wülfing C; von Struensee D; Bierer S; Bögemann M; Hertle L; Eltze E
Aktuelle Urol; 2005 Sep; 36(5):423-9. PubMed ID: 16163605
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and prognostic significance of HER-2/neu and VEGF expression in colon carcinomas.
Li Q; Wang D; Li J; Chen P
BMC Cancer; 2011 Jun; 11():277. PubMed ID: 21708009
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of hsa‑miR‑372 predicts poor prognosis in patients with gallbladder cancer by affecting chloride intracellular channel 1.
Zhou N; Cheng W; Peng C; Liu Y; Jiang B
Mol Med Rep; 2017 Nov; 16(5):7848-7854. PubMed ID: 28944858
[TBL] [Abstract][Full Text] [Related]
13. HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancer.
Schoppmann SF; Tamandl D; Roberts L; Jomrich G; Schoppmann A; Zwrtek R; Dubsky P; Gnant M; Jakesz R; Birner P
Ann Oncol; 2010 May; 21(5):955-60. PubMed ID: 19940005
[TBL] [Abstract][Full Text] [Related]
14. Fork head box M1 regulates vascular endothelial growth factor-A expression to promote the angiogenesis and tumor cell growth of gallbladder cancer.
Wang RT; Miao RC; Zhang X; Yang GH; Mu YP; Zhang ZY; Qu K; Liu C
World J Gastroenterol; 2021 Feb; 27(8):692-707. PubMed ID: 33716448
[TBL] [Abstract][Full Text] [Related]
15. HER2 status based on breast cancer guidelines as a useful prognostic marker of T2 gallbladder cancer.
Kwon CH; Seo HI; Kim DU; Han SY; Kim S; Lee SJ; Jeon DY
Eur J Surg Oncol; 2023 Feb; 49(2):392-398. PubMed ID: 36369228
[TBL] [Abstract][Full Text] [Related]
16. HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma.
Plum PS; Gebauer F; Krämer M; Alakus H; Berlth F; Chon SH; Schiffmann L; Zander T; Büttner R; Hölscher AH; Bruns CJ; Quaas A; Loeser H
BMC Cancer; 2019 Jan; 19(1):38. PubMed ID: 30621632
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of vascular endothelial growth factor A in advanced gallbladder carcinoma.
Letelier P; Garcia P; Leal P; Ili C; Buchegger K; Riquelme I; Sandoval A; Tapia O; Roa JC
Appl Immunohistochem Mol Morphol; 2014 Aug; 22(7):530-6. PubMed ID: 24185122
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of HER2/neu, p53, and vascular endothelial growth factor expression in early stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung.
Saad RS; Liu Y; Han H; Landreneau RJ; Silverman JF
Mod Pathol; 2004 Oct; 17(10):1235-42. PubMed ID: 15167937
[TBL] [Abstract][Full Text] [Related]
19. Association between HER-2/neu and vascular endothelial growth factor expression predicts clinical outcome in primary breast cancer patients.
Konecny GE; Meng YG; Untch M; Wang HJ; Bauerfeind I; Epstein M; Stieber P; Vernes JM; Gutierrez J; Hong K; Beryt M; Hepp H; Slamon DJ; Pegram MD
Clin Cancer Res; 2004 Mar; 10(5):1706-16. PubMed ID: 15014023
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological characteristics and outcomes of rare histologic subtypes of gallbladder cancer over two decades: A population-based study.
Samuel S; Mukherjee S; Ammannagari N; Pokuri VK; Kuvshinoff B; Groman A; LeVea CM; Iyer R
PLoS One; 2018; 13(6):e0198809. PubMed ID: 29889907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]